Ensysce Biosciences
Clinical trials sponsored by Ensysce Biosciences, explained in plain language.
-
New painkiller aims to ease tummy tuck recovery
Symptom relief Recruiting nowThis study tests a new oral painkiller called PF614 for people who have moderate to severe pain after a tummy tuck (abdominoplasty). About 320 adults will take either PF614 or a placebo before surgery and every 12 hours for up to 4 days. Researchers will measure pain levels and h…
Phase: PHASE3 • Sponsor: Ensysce Biosciences • Aim: Symptom relief
Last updated May 17, 2026 11:18 UTC
-
Healthy volunteers test new tamper-resistant painkiller combo
Knowledge-focused Recruiting nowThis early-stage study tests how a new painkiller (PF614) moves through the body when taken alone or with another drug (nafamostat). Thirty healthy adults aged 18 to 55 will receive a single dose, and researchers will measure drug levels in the blood over time. The goal is to und…
Phase: PHASE1 • Sponsor: Ensysce Biosciences • Aim: Knowledge-focused
Last updated May 17, 2026 11:08 UTC